Long non-coding RNA DSCAM-AS1 promotes pancreatic cancer progression via regulating the miR-136-5p/PBX3 axis

References

• Vincent A, Herman J, Schulick R, et al. Pancreatic cancer. Lancet. 2011 Aug 13;378(9791):607–620.
   PubMed Web of Science ®Google Scholar
• Chu LC, Goggins MG, Fishman EK. Diagnosis and detection of pancreatic cancer. Cancer J. 2017 Nov/Dec;23(6):333–342.
   PubMed Web of Science ®Google Scholar
• Gupta R, Amanam I, Chung V. Current and future therapies for advanced pancreatic cancer. Journal of Surgical Oncology. 2017 Jul;116(1):25–34.
   PubMed Web of Science ®Google Scholar
• Ilic M, Ilic I. Epidemiology of pancreatic cancer. World J Gastroenterol. 2016 Nov 28;22(44):9694–9705.
   PubMed Web of Science ®Google Scholar
• Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. 2017 Oct 12;36(41):5661–5667.
   PubMed Web of Science ®Google Scholar
• Wang J, Su Z, Lu S, et al. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clin Chim Acta. 2018 Oct;485:229–233.
   PubMed Web of Science ®Google Scholar
• Deng SJ, Chen HY, Ye Z, et al. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Oncogene. 2018 Nov;37(44):5811–5828.
   PubMed Web of Science ®Google Scholar
• Gao H, Gong N, Ma Z, et al. LncRNA ZEB2-AS1 promotes pancreatic cancer cell growth and invasion through regulating the miR-204/HMGB1 axis. Int J Biol Macromol. 2018 Sep;116:545–551.
   PubMed Web of Science ®Google Scholar
• Fu Z, Chen C, Zhou Q, et al. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Cancer Lett. 2017 Dec 1;410:68–81.
   PubMed Web of Science ®Google Scholar
• Liang WH, Li N, Yuan Z-Q. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2. Molecular Carcinogenesis. 2019 Apr;58(4):461–473.
   PubMed Web of Science ®Google Scholar
• Yu CL, Xu NW, Jiang W, et al. LncRNA DSCAM-AS1 promoted cell proliferation and invasion in osteosarcoma by sponging miR-101. Eur Rev Med Pharmacol Sci. 2020 Jul;24(14):7709–7717.
   PubMed Web of Science ®Google Scholar
• Hammond SM. An overview of microRNAs. Advanced drug delivery reviews. Advanced Drug Delivery Reviews. 2015 Jun 29;87:3–14.
   PubMed Web of Science ®Google Scholar
• Kang W, Wang Q, Dai Y, et al. Hypomethylation of PlncRNA-1 promoter enhances bladder cancer progression through the miR-136-5p/Smad3 axis. Cell Death Dis. 2020 Dec 7;11(12):1038.
   PubMed Web of Science ®Google Scholar
• Wang Z, Huang C, Zhang A, et al. Overexpression of circRNA_100290 promotes the progression of laryngeal squamous cell carcinoma through the miR-136-5p/RAP2C axis. Biomed Pharmacothe. 2020 May;125:109874.
   PubMed Web of Science ®Google Scholar
• Yang XL, Hao YJ, Wang B, et al. Long noncoding RNA NORAD promotes the progression of retinoblastoma by sponging miR-136-5p/PBX3 axis. Eur Rev Med Pharmacol Sci. 2020 Jan;24(3):1278–1287.
   PubMed Web of Science ®Google Scholar
• Yang XL, Hao YJ, Wang B, et al. Long noncoding RNA NORAD promotes the progression of retinoblastoma by sponging miR 136-5p/PBX3 axis. Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4055.
   PubMed Web of Science ®Google Scholar
• Qiu Z, Wang X, Shi Y, et al. miR-129-5p suppresses proliferation, migration, and induces apoptosis in pancreatic cancer cells by targeting PBX3. Acta Biochim Biophys Sin (Shanghai). 2019 Sep 6;51(10):997–1007.
   PubMed Web of Science ®Google Scholar
• Chen F, Mo J, Zhang L. Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription. Tumour Biol. 2016 Oct;37(10):13403–13412.
   PubMedGoogle Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method. Methods. 2001 Dec;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Luo J, Wang K, Yeh S, et al. LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling. Nat Commun. 2019 Jun 12;10(1). DOI:10.1038/s41467-019-09784-9.
   Google Scholar
• Bai T, Liu Y, Li B. LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. Iubmb Life. 2019 Oct;71(10):1537–1551.
   PubMed Web of Science ®Google Scholar
• Wang Z, Liu Z, Wu S. Long non-coding RNA CTA sensitizes osteosarcoma cells to doxorubicin through inhibition of autophagy. Oncotarget. 2017 May 9;8(19):31465–31477.
   PubMedGoogle Scholar
• Zeng Z, Xu FY, Zheng H, et al. LncRNA-MTA2TR functions as a promoter in pancreatic cancer via driving deacetylation-dependent accumulation of HIF-1α. Theranostics. 2019;9(18):5298–5314.
   PubMed Web of Science ®Google Scholar
• Jin X, Fang R, Fan P, et al. PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer. J Exp Clin Cancer Res. 2019 Nov 12;38(1):463.
   PubMed Web of Science ®Google Scholar
• Liu D, Rudland PS, Sibson DR, et al. Identification of mRNAs differentially-expressed between benign and malignant breast tumour cells. Br J Cancer. 2002 Aug 12;87(4):423–431.
   PubMed Web of Science ®Google Scholar
• Ghafouri-Fard S, Khoshbakht T, Taheri M, et al. A review on the carcinogenic roles of DSCAM-AS1. Front Cell Dev Biol. 2021 Oct 11;9. DOI:10.3389/fcell.2021.758513
   Web of Science ®Google Scholar
• Li B, Sun H, Zhang J. LncRNA DSCAM-AS1 promotes colorectal cancer progression by acting as a molecular sponge of miR-384 to modulate AKT3 expression. Aging (Albany NY). 2020 May 26;12(10):9781–9792.
   PubMedGoogle Scholar
• Liang J, Zhang S, Wang W, et al. Long non-coding RNA DSCAM-AS1 contributes to the tumorigenesis of cervical cancer by targeting miR-877-5p/ATXN7L3 axis. Biosci Rep. 2020 Jan 31;40(1). DOI:10.1042/BSR20192061.
   Google Scholar
• Qiu Z, Pan XX, You DY. LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis. Neoplasma. 2020 Jul;67(4):871–879.
   PubMed Web of Science ®Google Scholar
• Ji D, Hu G, Zhang X, et al. Long non-coding RNA DSCAM-AS1 accelerates the progression of hepatocellular carcinoma via sponging miR-338-3p. Am J Transl Res. 2019;11(7):4290–4302.
   PubMed Web of Science ®Google Scholar
• Cheng J, Meng J, Zhu L, et al. Exosomal noncoding RNAs in Glioma: biological functions and potential clinical applications. Mol Cancer. 2020 Mar 25;19(1):66.
   PubMed Web of Science ®Google Scholar
• Wang W, Hong G, Wang S, et al. Tumor-derived exosomal miRNA-141 promote angiogenesis and malignant progression of lung cancer by targeting growth arrest-specific homeobox gene (GAX). Bioengineered. 2021 Jan 1;12(1):821–831.
   PubMed Web of Science ®Google Scholar
• Lu N, Liu J, Ji C, et al. MiRNA based tumor mutation burden diagnostic and prognostic prediction models for endometrial cancer. Bioengineered. 2021 Jan 1;12(1):3603–3620.
   PubMed Web of Science ®Google Scholar
• Jiang H, Ge R, Chen S, et al. miRNA-204-5p acts as tumor suppressor to influence the invasion and migration of astrocytoma by targeting ezrin and is downregulated by DNA methylation. Bioengineered. 2021 Nov 1;12(2):9301–9312.
   PubMed Web of Science ®Google Scholar
• Hu S, Zhang J, Fang X, et al. Identification of microRNA hsa-miR-30c-5p as an inhibitory factor in the progression of hepatocellular carcinoma and investigation of its regulatory network via comprehensive analysis. Bioengineered. 2021 Jan 1;12(1):7165–7177.
   PubMed Web of Science ®Google Scholar
• Fan W, Yu X, Li K, et al. The alerting expression of microRNA-411 predicts clinical prognosis and regulates tumor progression of glioblastoma. Bioengineered. 2021 Jan 1;12(1):8650–8657.
   PubMed Web of Science ®Google Scholar
• Long K, Dong Q, Zeng W. The clinical significance of microRNA-409 in pancreatic carcinoma and associated tumor cellular functions. Bioengineered. 2021 Jan 1;12(1):4633–4642.
   PubMed Web of Science ®Google Scholar
• Chan JJ, Tay Y. Noncoding RNA:RNA Regulatory Networks in Cancer. Int J Mol Sci. 2018 Apr 27;19(5):1310.
   PubMed Web of Science ®Google Scholar
• Wang B, Liu H, Wang Z, et al. Long non-coding RNA DSCAM-AS1 promotes the progression of gastric cancer via targeting miR-101-3p. Panminerva Med. 2019 Dec 17. DOI:10.23736/S0031-0808.19.03814-X.
   Google Scholar
• Liu F, Jia J, Sun L, et al. lncRNA DSCAM-AS1 downregulates miR-216b to promote the migration and invasion of colorectal adenocarcinoma cells. Onco Targets Ther. 2019;12:6789–6795.
   PubMed Web of Science ®Google Scholar
• Ding H, Ye Z-H, Wen D-Y, et al. Downregulation of miR-136-5p in hepatocellular carcinoma and its clinicopathological significance. Mol Med Rep. 2017 Oct;16(4):5393–5405.
   PubMed Web of Science ®Google Scholar
• Gu G, Hu C, Hui K, et al. Exosomal miR-136-5p derived from anlotinib-resistant NSCLC cells confers anlotinib resistance in non-small cell lung cancer through targeting PPP2R2A. Int J Nanomedicine. 2021;16:6329–6343.
   PubMed Web of Science ®Google Scholar
• Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4(1):199–227.
   PubMed Web of Science ®Google Scholar
• Ji Q, Xu X, Song Q, et al. miR-223-3p inhibits human osteosarcoma metastasis and progression by directly targeting CDH6. Mol Ther. 2018 May 2;26(5):1299–1312.
   PubMed Web of Science ®Google Scholar
• Xu J, Yao Q, Hou Y, et al. MiR-223/Ect2/p21 signaling regulates osteosarcoma cell cycle progression and proliferation. Biomed Pharmacothe. 2013 Jun;67(5):381–386.
   PubMed Web of Science ®Google Scholar
• Zhao J, Yang T, Li L. LncRNA FOXP4-AS1 is involved in cervical cancer progression via regulating miR-136-5p/CBX4 axis. Onco Targets Ther. 2020;13:2347–2355.
   PubMed Web of Science ®Google Scholar
• Geng Y, Bao Y, Zhang W, et al. Circular RNA hsa_circ_0014130 inhibits apoptosis in non-small cell lung cancer by sponging miR-136-5p and upregulating BCL2. Mol Cancer Res. 2020 May;18(5):748–756.
   PubMed Web of Science ®Google Scholar
• Yang B, Zang J, Yuan W, et al. The miR-136-5p/ROCK1 axis suppresses invasion and migration, and enhances cisplatin sensitivity in head and neck cancer cells. Exp Ther Med. 2021 Apr;21(4):317.
   PubMed Web of Science ®Google Scholar
• Liu D, Kang H, Gao M, et al. Exosome-transmitted circ_MMP2 promotes hepatocellular carcinoma metastasis by upregulating MMP2. Molecular Oncology. 2020 Jun;14(6):1365–1380.
   PubMed Web of Science ®Google Scholar
• Lu X, Gao H, Zhu B, et al. Circular RNA circ_RANBP9 exacerbates polycystic ovary syndrome via microRNA-136-5p/XIAP axis. Bioengineered. 2021 Jan 1;12(1):6748–6758.
   PubMed Web of Science ®Google Scholar